Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer
Maryann Kwa(NYU Langone Health), Xiaochun Li(NYU Langone Health), Yelena Novik(NYU Langone Health), Ruth Oratz(NYU Langone Health), Komal Jhaveri(Memorial Sloan Kettering Cancer Center), Jennifer Wu(NYU Langone Health), Ping Gu(NYU Langone Health), Marleen Meyers(NYU Langone Health), Franco M. Muggia(NYU Langone Health), James L. Speyer(NYU Langone Health), Alyssa Iwano(NYU Langone Health), Maryam Bonakdar(NYU Langone Health), Lina Kozhaya(Jackson Laboratory), Ece Tavukçuoğlu(NYU Langone Health), Bahar Budan(NYU Langone Health), Roy A. Raad(NYU Langone Health), Judith D. Goldberg(NYU Langone Health), Derya Unutmaz(NYU Langone Health), Sylvia Adams(NYU Langone Health)
Cited by 22
Abstract
Related Papers
No related papers found
Powered by citation graph analysis